SCHEMBL13484170

SCHEMBL13484170

Cc1ccc(N)c(CF)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
ALOX15 P16050 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CYP3A4 P08684 2/20 0.52
TP53 P04637 1/20 0.52
THRB P10828 1/20 0.52
ALDH1A1 P00352 3/20 0.44
TAAR1 Q96RJ0 1/20 0.42
HSD17B10 Q99714 1/20 0.41
CA1 P00915 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ATP4A P20648 1/20 0.37
ATP4B P51164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12463289 0.81 ALOX15 (0.56) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL3682215 0.79 TDP1 (0.54) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL1352508 0.79 TDP1 (0.54) TDP1ALOX15SMN1; SMN2CYP3A4TP53
Hydrochloric Acid SCHEMBL27848958 0.77 TDP1 (0.52) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL1352506 0.77 TDP1 (0.52) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL356244 0.77 ALOX15 (0.52) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL9508003 0.77 TDP1 (0.52) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL21292117 0.77 SMN1; SMN2 (0.46) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL16129049 0.77 SMN1; SMN2 (0.46) TDP1ALOX15SMN1; SMN2CYP3A4TP53
SCHEMBL28578528 0.76 CASP1 (0.37) TDP1ALOX15CYP3A4TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7655688-B2 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione BRISTOL-MYERS SQUIBB COMPANY (US) 2010-02-02 US disclosed
US-RE40525-E1 Hepatitis C inhibitor tri-peptides BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2008-09-30 US disclosed